A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas

Por Kreisl, Teri N., Kotliarova, Svetlana, Butman, John A., Albert, Paul S., Kim, Lyndon, Musib, Luna, Thornton, Donald, Fine, Howard A.
Publicado em 2010

A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities

Por Lu, Dan, Lu, Tong, Stroh, Mark, Graham, Richard A., Agarwal, Priya, Musib, Luna, Li, Chi-Chung, Lum, Bert L., Joshi, Amita
Publicado no Cancer Chemother Pharmacol (2016)

Safety of an IV Formulation of Carbamazepine

Por Conway, Jeannine M., White, James R., Birnbaum, Angela K., Ramsay, R. Eugene, Pennell, Page B., Rarick, John O., Musib, Luna, Leppik, Ilo E., Cloyd, James C.
Publicado em 2009

Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study(†)

Por Butowski, Nicholas, Chang, Susan M., Lamborn, Kathleen R., Polley, Mei Yin, Parvataneni, R., Hristova-Kazmierski, Maria, Musib, Luna, Nicol, Steven J., Thornton, Donald E., Prados, Michael D.
Publicado em 2010

Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

Por Wick, Wolfgang, Puduvalli, Vinay K., Chamberlain, Marc C., van den Bent, Martin J., Carpentier, Antoine F., Cher, Lawrence M., Mason, Warren, Weller, Michael, Hong, Shengyan, Musib, Luna, Liepa, Astra M., Thornton, Donald E., Fine, Howard A.
Publicado em 2010

A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors

Por Saura, Cristina, Roda, Desamparados, Roselló, Susana, Oliveira, Mafalda, Macarulla, Teresa, Pérez-Fidalgo, José Alejandro, Morales-Barrera, Rafael, Sanchis-García, Juan Manuel, Musib, Luna, Budha, Nageshwar, Zhu, Jin, Nannini, Michelle, Chan, Wai Y., Sanabria Bohórquez, Sandra M., Meng, Raymond D., Lin, Kui, Yan, Yibing, Patel, Premal, Baselga, José, Tabernero, Josep, Cervantes, Andrés
Publicado no Cancer Discov (2016)